30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

LDR received FDA approval to market the Mobi-C® Cervical Disc for 1-level indications. In the 1-level arm of the Investigational Device Exemption study, Mobi-C demonstrated non-inferiority in overall trial success vs. anterior cervical discectomy fusion. (LDR, 8/8/13)